327 related articles for article (PubMed ID: 38109001)
1. Application potential of senolytics in clinical treatment.
Li T; Li S; Ma K; Kong J
Biogerontology; 2024 Jun; 25(3):379-398. PubMed ID: 38109001
[TBL] [Abstract][Full Text] [Related]
2. The potential of Senolytics in transplantation.
Matsunaga T; Iske J; Schroeter A; Azuma H; Zhou H; Tullius SG
Mech Ageing Dev; 2021 Dec; 200():111582. PubMed ID: 34606875
[TBL] [Abstract][Full Text] [Related]
3. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.
Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
FEBS J; 2023 Mar; 290(5):1362-1383. PubMed ID: 35015337
[TBL] [Abstract][Full Text] [Related]
4. Potential Use of Senolytics for Pharmacological Targeting of Precancerous Lesions.
Saleh T; Carpenter VJ
Mol Pharmacol; 2021 Dec; 100(6):580-587. PubMed ID: 34544896
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the discovery of senolytics.
Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
Mech Ageing Dev; 2021 Dec; 200():111587. PubMed ID: 34656616
[TBL] [Abstract][Full Text] [Related]
6. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases.
Lagoumtzi SM; Chondrogianni N
Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756
[TBL] [Abstract][Full Text] [Related]
7. Strategies for late phase preclinical and early clinical trials of senolytics.
Wissler Gerdes EO; Misra A; Netto JME; Tchkonia T; Kirkland JL
Mech Ageing Dev; 2021 Dec; 200():111591. PubMed ID: 34699859
[TBL] [Abstract][Full Text] [Related]
8. Promises and challenges of senolytics in skin regeneration, pathology and ageing.
Pils V; Ring N; Valdivieso K; Lämmermann I; Gruber F; Schosserer M; Grillari J; Ogrodnik M
Mech Ageing Dev; 2021 Dec; 200():111588. PubMed ID: 34678388
[TBL] [Abstract][Full Text] [Related]
9. Senescence and senolytics in cardiovascular disease: Promise and potential pitfalls.
Owens WA; Walaszczyk A; Spyridopoulos I; Dookun E; Richardson GD
Mech Ageing Dev; 2021 Sep; 198():111540. PubMed ID: 34237321
[TBL] [Abstract][Full Text] [Related]
10. Senolytic drugs: from discovery to translation.
Kirkland JL; Tchkonia T
J Intern Med; 2020 Nov; 288(5):518-536. PubMed ID: 32686219
[TBL] [Abstract][Full Text] [Related]
11. A guide to senolytic intervention in neurodegenerative disease.
Lee S; Wang EY; Steinberg AB; Walton CC; Chinta SJ; Andersen JK
Mech Ageing Dev; 2021 Dec; 200():111585. PubMed ID: 34627838
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Potential of Senolytics in Cardiovascular Disease.
Dookun E; Passos JF; Arthur HM; Richardson GD
Cardiovasc Drugs Ther; 2022 Feb; 36(1):187-196. PubMed ID: 32979174
[TBL] [Abstract][Full Text] [Related]
13. Senotherapeutics to Counteract Senescent Cells Are Prominent Topics in the Context of Anti-Ageing Strategies.
Calabrò A; Accardi G; Aiello A; Caruso C; Galimberti D; Candore G
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339070
[TBL] [Abstract][Full Text] [Related]
14. Senolytics and the compression of late-life mortality.
Kowald A; Kirkwood TBL
Exp Gerontol; 2021 Nov; 155():111588. PubMed ID: 34637949
[TBL] [Abstract][Full Text] [Related]
15. Biomolecular Evaluation of Piceatannol's Effects in Counteracting the Senescence of Mesenchymal Stromal Cells: A New Candidate for Senotherapeutics?
Alessio N; Squillaro T; Lettiero I; Galano G; De Rosa R; Peluso G; Galderisi U; Di Bernardo G
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769049
[TBL] [Abstract][Full Text] [Related]
16. Obesity, Senescence, and Senolytics.
Chaib S; Tchkonia T; Kirkland JL
Handb Exp Pharmacol; 2022; 274():165-180. PubMed ID: 34697668
[TBL] [Abstract][Full Text] [Related]
17. Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies.
Khalil R; Diab-Assaf M; Lemaitre JM
Cells; 2023 Mar; 12(6):. PubMed ID: 36980256
[TBL] [Abstract][Full Text] [Related]
18. A geroscience motivated approach to treat Alzheimer's disease: Senolytics move to clinical trials.
Gonzales MM; Krishnamurthy S; Garbarino V; Daeihagh AS; Gillispie GJ; Deep G; Craft S; Orr ME
Mech Ageing Dev; 2021 Dec; 200():111589. PubMed ID: 34687726
[TBL] [Abstract][Full Text] [Related]
19. Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans.
Zhu Y; Prata LGPL; Gerdes EOW; Netto JME; Pirtskhalava T; Giorgadze N; Tripathi U; Inman CL; Johnson KO; Xue A; Palmer AK; Chen T; Schaefer K; Justice JN; Nambiar AM; Musi N; Kritchevsky SB; Chen J; Khosla S; Jurk D; Schafer MJ; Tchkonia T; Kirkland JL
EBioMedicine; 2022 Mar; 77():103912. PubMed ID: 35292270
[TBL] [Abstract][Full Text] [Related]
20. The role of senolytics in osteoporosis and other skeletal pathologies.
Doolittle ML; Monroe DG; Farr JN; Khosla S
Mech Ageing Dev; 2021 Oct; 199():111565. PubMed ID: 34499959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
